Sentences with phrase «for early cancer»

«As with the medical profession, where AI tools are already being used for early cancer diagnosis, lawyers will increasingly use AI as a diagnostic tool to support their work in myriad ways,» wrote Robert Morley, COO at Excello Law, earlier this year.

Scientists at Northwestern University and the Field Museum of Natural History asked themselves that very question, and they think they found the answer using optical technology designed for early cancer detection.

The goal for this Foundation is to use a dog's sensitive nose to provide a diagnostic screening option for early cancer detection in people.

Our pets will benefit from research into the causes of cancer, new treatment modalities, new tests for early cancer detection and new drugs to treat cancer.

-- «Cellulose Nanocrystal Cantilever Beam Array MEMS for Early Cancer Detection,» led by Dr. Virginia A. Davis, Department of Chemical Engineering.

Using dogs for early cancer detection is not an accepted method of screening, however, and likely won't be, because dogs are harder to control, cost a lot to care for, and need training, the article said.

The most important point, he said, is the need for early cancer detection — something that medicine now is «very bad» at.

«This study will inform development of technology for a future test that could eventually be used as a blood test for early cancer detection.

This innovative approach — using high - intensity sequencing to detect cancer from circulating tumor DNA in the bloodstream — heralds the development of future tests for early cancer detection.

By interfacing brain cells onto graphene, researchers at the University of Illinois at Chicago have shown they can differentiate a single hyperactive cancerous cell from a normal cell, pointing the way to developing a simple, noninvasive tool for early cancer diagnosis.

Tumor biopsy is often impossible for early cancer diagnosis as the developing tumor is too small to see by the current imaging tools.

Singlera Genomics, a developer of tests for early cancer detection, said Wednesday it has raised $ 60 million in venture capital.

Not exact matches

Shares of cancer - focused biotech Clovis Oncology soared nearly 50 % in early Monday trading on the strength of clinical trial results for its ovarian cancer treatment Rubraca.

A great example of this is a health - care organization called TGEN, which is focused on developing ways to diagnose cancer earlier and provide smarter treatments for patients.

That leaves Merck largely free of competitors in the near - term in its quest to become a go - to, first - line option for lung cancer patients in combination with chemotherapy (Merck recently surprised investors with an early FDA filing for that combination).

The marketing is edgy: October's «Touch Yourself» campaign in partnership with Women's Health and Men's Health magazines ditches traditional pink National Breast Cancer Awareness Month branding in favor of a naked woman holding her breasts, encouraging women to do self - exams for early detection.

That research will be crucial: An earlier effort by another company, Pathway Genomics, to create a «liquid biopsy» for cancer was greeted in September by a stern letter from the Food and Drug Administration (FDA) warning that the agency had «not found any published evidence that this test or any similar test has been clinically validated as a screening tool for early detection of cancer in high risk individuals.»

But the ways that CTDNA screening could work, and the opportunities that screening creates for early treatment, could revolutionize cancer treatment in ways that «can not be overemphasized,» according to Baselga.

Conrad told Inc. in March that he got the idea for Zenefits when he was researching health care benefits for employees at an earlier startup, and because he is a cancer survivor with an ongoing interest in health care coverage.

Intuitive has teamed up with China's Fosun Pharma, for instance, in a joint venture to detect lung cancers in their earliest stages, developing a flexible robotic catheter that can navigate into the cavernous regions of the lungs.

And they now have the option, in terms of self - managing their care with their own primary care physician, to be more on the lookout for any other symptoms of cancer, so we can catch it early.»

Blackmun stepped down earlier this week to deal with prostate cancer, though Raisman, several high - profile gymnasts and two U.S. Senators had been calling for his ouster for weeks.

The company is also working on an imaging device for early detection of lung, colon and cervical cancer.

A veteran of digital imaging technology, in 1999 he founded Quantitative Imaging Corp. (QImaging), a manufacturer of digital cameras for scientific and industrial uses — the kind, for example, that can detect microscopic, early - stage cancer cells.

Phil Knight and OHSU have raised $ 1 billion for the detection of lethal cancers in their early stages.

Shares of Clovis Oncology closed up 8.82 percent Monday as the company received early approval for its advanced ovarian cancer drug Rubraca (rucaparib).

Helmy Eltoukhy, Co-founder and CEO, Guardant Health Dr. Sam Hanash, Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center Dr. Anirban Maitra, Scientific Director, Sheikh Ahmed Center for Pancreatic Cancer Research, MD Anderson Cancer Center Moderator: Clifton Leaf, Fortune

NEW YORK (360Dx)-- Biotech firm Berg continued its push into cancer diagnostics with the presentation of several posters earlier this month at the annual meeting of the American Association for Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpcancer diagnostics with the presentation of several posters earlier this month at the annual meeting of the American Association for Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpCancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpcancer and benign prostate hyperplasia.

Early this month, Predible Health Pvt. Ltd, a startup that builds AI - powered apps that interpret medical scans for radiologists diagnosing cancer, raised an undisclosed amount from Unitus Seed Fund, a seed - stage impact venture player.

The corporation was spun out of the Ontario Institute for Cancer Research (OICR) to develop and advance late pre-clinical, Phase I or early Phase II potential products.

Proteocyte Diagnostics, a company with a unique test for early identification of oral cancers, announced today that it has officially joined MaRS» SVX (Social Venture Connexion).

Proteocyte Diagnostics Inc., a company with a unique test for early identification of oral cancers, today announced an investment by Freycinet Investments, made possible by MaRS» SVX (Social Venture Connexion) impact investing platform.

The Ontario Institute for Cancer Research is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cCancer Research is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of ccancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancercancer.

About Social Venture Connexion SVX (@theSVX) is a full service impact investing platform that connects impact ventures and funds with accredited investors looking to make investments with demonstrable social and / or environmental impact and the potential for financial return, from nonprofit education projects to health ventures focused on early cancer detection.

VICTORIA — New Democrat spokesperson for health, Judy Darcy, is congratulating advocates who have won improved treatment for the late effects of early childhood cancer.

On any given day, Canada's leading researchers unravel the mysteries of biology in state - of - the - art labs throughout the Toronto Medical Discovery Tower and the Ontario Institute for Cancer Research; early - stage science and technology companies put business plans into action in the MaRS Incubator; organizations across the innovation spectrum grow their businesses in the Heritage Building — the original brick façade of the old Toronto General Hospital.

TORONTO, July 15, 2014 — Proteocyte Diagnostics, a company with a unique test for early identification of oral cancers, announced today that it has officially joined MaRS» SVX (Social Venture Connexion).

In the drive to improve early detection and treatment of cancer, a pair of Toronto scientists has developed a unique technology that combines contrast agents with targeted, long - lasting nano - particles for use in multiple medical imaging platforms.

It has high hopes for approvals of earlier use of Ibrance and the prostate cancer drug Xtandi that would boost sales.

Furthermore, Celgene is generating free cash flow at a rate of over $ 1 billion per quarter, giving it plenty of options to acquire new drugs, such as with the deal it announced earlier this month to buy Impact Biomedicines and its potential blockbuster drug for a rare form of blood cancer, and its latest announced buyout of CAR - T developer Juno Therapeutics.

The FDA approved a Lutetium - 177 based cancer therapy called Lutathera for the treatment of neuroendocrine tumors earlier this year, after Novartis snapped up the developer, Advanced Accelerator, at a premium.

Half are for various forms of cancer; the other half represent a cluster of rare diseases, including early - onset Alzheimer's.

But he approves of it in the case of a physician who» knowingly facilitated» the suicide of a patient whom he had treated for a long time, knew well, and who had convinced him early on that she preferred to die rather than go through a long and losing battle with cancer.

In early November, for instance, Francis Phillips, in her Catholic Herald blog, scored something of a bull's eye, with a post in which she pointed out that Tesco had ended its support for a major cancer research event, but instead made a large contribution to London's main annual gay prideevent.

I do have great difficulty with the first thought — after all, my brother in law died of cancer in early 2014, when he cared for 3 natural children and 11 adopted ones.

The early Christians were learning what Christians today believe, that God was in the process of revealing his message to them; and, the message is: the end will come soon enough; we will be judged for everything we have done while in the body; that only God through Christ's death on the cross can atone for our sins; and, we should remain vigilant and be prepared for the end — whether that comes in the form of natural death, through cancer, car accidents, coronary heart disease or some other form.

Constant ovulation is not normal nor healthy for their bodies and increases their risk for ovarian cancer, uterine prolapse and other reproductive diseases causing early death (which is why they are sent to slaughter for cheap meat in the egg industry).

My mom underwent treatment for breast cancer a few years ago, and we were blessed that it was detected early and that she was able to pull through and is now healthy.

Electrolux and Kelly Ripa are proud to support the Ovarian Cancer Research Fund whose mission is to fund research to find a method of early detection and ultimately a cure for Ovarian Cancer.

I am really enjoying my training in nutritional and environmental medicine that you checked out for me earlier this year and curcumin is covered in the cancer lecture.